Wall Street analyst price targets, ratings consensus & upside potential · Updated Feb 28, 2026
Last 12 months price action with 12-month analyst target path
As of March 2, 2026, Cogent Biosciences, Inc. (COGT) has a Wall Street consensus price target of $48.13, based on estimates from 12 covering analysts. With the stock currently trading at $38.85, this represents a potential upside of +23.9%. The company has a market capitalization of $6.25B.
Analyst price targets range from a low of $35.00 to a high of $60.00, representing a 52% spread in expectations. The median target of $50.00 aligns closely with the consensus average. The wide target spread reflects significant disagreement on fair value.
The current analyst consensus rating is Buy, with 10 analysts rating the stock as a Buy or Strong Buy,2 rating it Hold, and 0 rating it Sell or Strong Sell. This overwhelmingly bullish sentiment suggests analysts see significant catalysts for upside ahead.
From a valuation perspective, COGT trades at a trailing P/E of -15.2x. Analysts expect EPS to grow +57.6% over the next year.
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorSee our Bear / Base / Bull DCF models and intrinsic value estimates.
View ValuationSee how COGT stacks up against sector leader Agios Pharmaceuticals, Inc..
Start ComparisonThe consensus Wall Street price target for COGT is $48.13, representing 23.9% upside from the current price of $38.85. With 12 analysts covering the stock, this strong upside suggests significant value not yet reflected in today's share price.
COGT has a consensus rating of "Buy" based on 12 Wall Street analysts. The rating breakdown is predominantly bullish, with 10 Buy/Strong Buy ratings. The consensus 12-month price target of $48.13 implies 23.9% upside from current levels.
COGT's current price is $38.85 with a consensus target of $48.13 (23.9% implied move). Analyst estimates suggest the stock is undervalued at current levels.
The most bullish Wall Street analyst has a price target of $60 for COGT, while the most conservative target is $35. The consensus of $48.13 represents the median expectation. These targets typically reflect 12-month expectations.
COGT is moderately covered, with 12 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 10 have Buy ratings, 2 recommend Hold, and 0 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
The 12-month COGT stock forecast based on 12 Wall Street analysts shows a consensus price target of $48.13, with estimates ranging from $35 (bear case) to $60 (bull case). The median consensus rating is "Buy".
Wall Street analysts are very optimistic on COGT, with a "Buy" consensus rating and $48.13 price target (23.9% upside). 10 of 12 analysts rate it Buy or Strong Buy. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
COGT analyst price targets range from $35 to $60, a 52% wide spread indicating significant analyst disagreement. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $48.13 consensus represents the middle ground.